Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Unni S. Pillai"'
Autor:
Smita Kayal, Kadambari Dharanipragada, Sunu Lazar Cyriac, Unni S Pillai, Dhanraju Krishnappa Muniswamy, Dhanapathi Halanaik, Navin Kumar, Yadav Nisha, Biswajit Dubashi, Ponraj Madasamy, Sadishkumar Kamalanathan
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Purpose: To study the late toxicities of treatment and its impact on Breast cancer survivors among Indian patients. Materials and Methods: Our study recruited 152 curatively treated non metastatic carcinoma breast patients. The baseline demographic d
Autor:
Unni S Pillai, Kolar Vishwanath Vinod, Ponraj Madasamy, Naresh Jadhav, Hanumanthappa Nandeesha, Smita Kayal, Debdatta Basu, Ranjith Kumar, Biswajit Dubashi, Jogamaya Pattnaik
Publikováno v:
Supportive Care in Cancer. 28:731-738
Anemia is a common finding and important cause of morbidity in patients with acute lymphoblastic leukemia (ALL) at diagnosis or during the course of its protracted treatment. We studied profile of anemia in ALL patients on maintenance therapy and eva
Autor:
Amit Dutt Dwary, Kayathanahalli Govindachar Srinivas, Ajay Bapna, Suresh H. Advani, Nagendra Ramanjinappa, Unni S. Pillai, Vamshi Krishna, P. Vijay Anand Reddy, Anjana Joel, Manikandan Dhanushkodi, Smruti B. Koppikar, Dinesh Chandra Doval, S. V. S. S. Prasad, Prasad Narayanan
Publikováno v:
Indian Journal of Gynecologic Oncology. 19
Purpose To discuss and reach a consensus on the use of bevacizumab in women with advanced ovarian cancer in Indian settings. Methods An advisory board meeting comprising Indian oncologists was convened to review key literature available on the role o
Autor:
Bhanu Prakash, Naresh Jadhav, Sunu Lazar Cyriac, K Ranjith, Jogamaya Pattnaik, B H Harish, Esha Jaffa, Kiran Kumar Matta, Jagdeep Singh, Unni S Pillai, M Ponraj, Biswajit Dubashi, Smita Kayal
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(11)
Beta lactams are standard empirical therapy for febrile neutropenia (FN). The aim of this study was to evaluate the efficacy and safety of cefepime monotherapy compared with cefoperazone/sulbactam plus amikacin (CS + A) for empirical treatment of hig
Publikováno v:
Annals of Oncology. 26:ix156